Novartis | Cassa E Equivalenti

Prezzo Delle Azioni
156.42
Cambio Giornaliero
2.62 1.70%
Mensile
10.22%
Annuale
47.28%
Q1 Previsione
152.60




Cassa E Equivalenti Cambiamento Data
AbbVie USD 5.63B 838M 2025-09
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
Bausch Health Companies USD 1.31B 419M 2025-09
Biogen USD 3.01B 854.3M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Canopy Growth CAD 298.06M 171.86M 2025-09
Corcept Therapeutics USD 125.14M 22.39M 2025-09
Drreddys Laboratories INR 18.66B 9.65B 2025-12
Eli Lilly USD 9.79B 6.42B 2025-09
Gilead Sciences USD 5.14B 2.78B 2025-06
GlaxoSmithKline GBP 3.3B 303M 2025-09
Glaxosmithkline GBP 3.3B 303M 2025-09
J&J USD 18.23B 10.35B 2025-09
Merck USD 18.17B 10.16B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Pacira USD 147.59M 152.89M 2025-09
Perrigo USD 432.1M 22.1M 2025-09
Pfizer USD 1.34B 295M 2025-09
Prestige Brands USD 62.37M 56.73M 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sanofi EUR 7.66B 1.25B 2025-12
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09
Zoetis USD 2.08B 649M 2025-09


Novartis Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.